Comparison of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder cancer

International Braz J Urol

Volumn 33, Issue 1, 2007, Pages 25-31

  McLaughlin, Sean ^a   Shephard, Jon ^a   Wallen, Eric ^a   Maygarden, Susan ^a   Carson, Culley C ^a   Pruthi, Raj S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Bladder cancer; Cystectomy; Neoplasm staging; Pathology

Indexed keywords

EID: 33947358619     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/s1677-55382007000100005     Document Type: Article

References (17)

1. Underwood W 3rd, Dunn RL, Williams C, Lee CT: Gender and geographic influence on the racial disparity in bladder cancer mortality in the US. J Am Coll Surg. 2006; 202: 284-90.
2. Chang SS, Hassan JM, Cookson MS, Wells N, Smith JA Jr: Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol. 2003; 170: 1085-7.
3. Sanchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB: An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol. 2003; 169: 110-5; discussion 115.
4. Tsukamoto T, Kitamura H, Takahashi A, Masumori N: Treatment of invasive bladder cancer: lessons from the past and perspective for the future. Jpn J Clin Oncol. 2004; 34: 295-306.
5. Deserno WM, Harisinghani MG, Taupitz M, Jager GJ, Witjes JA, Mulders PF, et al.: Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology. 2004; 233: 449-56.
6. Habuchi T, Marberger M, Droller MJ, Hemstreet GP 3rd, Grossman HB, Schalken JA, et al.: Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology. 2005; 66: 64-74.
7. Malats N, Bustos A, Nascimento CM, Fernandez F, Rivas M, Puente D, et al.: P53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol. 2005; 6: 678-86.
8. Sherif A, Garske U, de la Torre M, Thorn M: Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol. 2006; 50: 83-91.
9. Liedberg F, Chebil G, Davidsson T, Gudjonsson S, Mansson W: Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer. J Urol. 2006; 175: 84-8; discussion 88-9.
10. Paik ML, Scolieri MJ, Brown SL, Spirnak JP, Resnick MI: Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol. 2000; 163: 1693-6.
11. Barentsz JO, Witjes JA, Ruijs JH: What is new in bladder cancer imaging. Urol Clin North Am. 1997; 24: 583-602.
12. Herr HW: Routine CT scan in cystectomy patients: does it change management? Urology. 1996; 47: 324-5. Erratum in: Urology 1996 May;47(5):785.
13. Shvarts O, Han KR, Seltzer M, Pantuck AJ, Belldegrun AS: Positron emission tomography in urologic oncology. Cancer Control. 2002; 9: 335-42.
14. Hain SF, Maisey MN: Positron emission tomography for urological tumours. BJU Int. 2003; 92: 159-64.
15. Schoder H, Larson SM: Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004; 34: 274-92.
16. Bayraktar Z, Gurbuz G, Tasci AI, Sevin G: Staging error in the bladder tumor: the correlation between stage of TUR and cystectomy. Int Urol Nephrol. 2001; 33: 627-9.
17. Dalbagni G, Herr HW, Reuter VE: Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology. 2002; 60: 822-4; discussion 824-5.